Repligen
RGEN
#2328
Rank
A$11.72 B
Marketcap
A$207.88
Share price
-1.20%
Change (1 day)
18.21%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): A$0.12 Billion

According to Repligen 's latest financial reports the company's current earnings are A$0.73 Billion. , an increase over its 2024 earnings that were of -A$9.01 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 A$0.11 B-1430.84%
2024 -A$9.01 Million-113.01%
2023 A$69.22 M-78.01%
2022 A$0.31 B33.37%
2021 A$0.23 B131.52%
2020 A$0.10 B101.31%
2019 A$50.64 M25.93%
2018 A$40.21 M105.61%
2017 A$19.55 M-11.46%
2016 A$22.09 M14.91%
2015 A$19.22 M20.26%
2014 A$15.98 M-51.49%
2013 A$32.95 M90.98%
2012 A$17.25 M
2010 A$0.25 M-103.81%
2009 -A$6.56 Million-223.84%
2008 A$5.29 M
2006 -A$3.56 Million229.64%
2005 -A$1.08 Million-89.16%
2004 -A$9.96 Million-16.86%
2003 -A$11.98 Million88.72%
2002 -A$6.35 Million-27.88%
2001 -A$8.8 Million-1.74%
2000 -A$8.96 Million85.93%
1999 -A$4.82 Million159.16%
1998 -A$1.86 Million85.71%
1997 -A$1.01 Million-70.83%
1996 -A$3.43 Million-72.41%
1995 -A$12.44 Million-60.63%
1994 -A$31.58 Million45.39%
1993 -A$21.72 Million39.45%
1992 -A$15.58 Million-32.3%
1991 -A$23.01 Million6.62%
1990 -A$21.58 Million1577.78%
1989 -A$1.29 Million-57.14%
1988 -A$3.01 Million-362.5%
1987 A$1.14 M-130.77%
1986 -A$3.72 Million136.36%
1985 -A$1.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$15.13 B 12,523.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$10.60 B 8,746.67%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$15.68 B 12,988.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.71 B 11,339.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.16 Billion-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$0.66 B 453.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$1.14 B 852.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.17 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.55 B 359.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-A$0.15 Billion-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA